Sohm wrapped up 2013 with expectations of full-year revenue growth of more than 55 percent. Such a bold outlook is supported by a year of achievements and product launches.
Sohm is a generic pharmaceutical manufacturer, developer, and marketer of a wide range of products serving a broad segment of the therapeutics market. In February 2013, the company marked its entrance into the United States’ lucrative cosmeceutical market with the U.S. launch of its flagship skincare product called “FoHM by SOHM™. This wasn’t any ordinary launch. Sohm was asked and obliged to be a sponsor of one of the Oscar After Parties, placing its product in more than 300 celebrity gift bags.
FoHM by SOHM contributed to the company’s first-quarter revenues, which achieved triple-digit growth of 267 percent. The main driver, however, was the company’s concentrated efforts to develop its over-the-counter (OTC) generic drug business.
In August, Sohm opened up another revenue stream by unveiling a unique, first-of-its-kind protein supplement called I-Prolec™ in India. I-Prolec™ as designed to help people who have protein deficiency as well as athlete and sports persons who have need of extra proteins, especially for vegetarian diet.
By November, Sohm was ready to announce the expansion of its cosmeceutical product line with the introduction of its Salic-2® Gel acne treatment. A few days later, Sohm launched its umbrella brand, “SohMed™,” providing the company with a stronger footing in the OTC medicines segment.
In announcing its results for the first half of 2013, Sohm posted revenue growth of 116 percent, reporting that nine-month revenue of $1.5 million had already surpassed revenue of $1.2 million achieved in full-year 2012. This impressive growth, supported by an equally as impressive year of product launches, validated Sohm’s double-digit full-year guidance, as earlier noted.
For more information, visit www.sohm.com
Let us hear your thoughts: Sohm, Inc. Message Board